The Safety of Atovaquone/Proguanil in Long-Term Malaria Prophylaxis of Nonimmune Adults
Open Access
- 8 March 2006
- journal article
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 10 (suppl_1) , S13-S15
- https://doi.org/10.2310/7060.2003.35050
Abstract
Background. Data on the long-term safety of atovaquone/proguanil in nonimmune travelers are limited.Methods. An open-label study, involving 300 DanishKeywords
This publication has 9 references indexed in Scilit:
- Reported Side Effects to Chloroquine, Chloroquine plus Proguanil, and Mefloquine as Chemoprophylaxis against Malaria in Danish TravelersJournal of Travel Medicine, 2006
- Atovaquone‐Proguanil versus Mefloquine for Malaria Prophylaxis in Nonimmune Travelers: Results from a Randomized, Double‐Blind StudyClinical Infectious Diseases, 2001
- Causal prophylactic efficacy of atovaquone-proguanil (MalaroneTM) in a human challenge modelTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001
- Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind studyThe Lancet, 2000
- The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone™) and chloroquineTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.The American Journal of Tropical Medicine and Hygiene, 1999
- Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.The American Journal of Tropical Medicine and Hygiene, 1999
- Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in childrenThe Lancet, 1998
- Atovaquone and proguanil for Plasmodium falciparum malariaThe Lancet, 1996